Phenotypic dichotomy in mitochondrial complex II genetic disorders

Journal of Molecular Medicine

Volumn 79, Issue 9, 2001, Pages 495-503

  Baysal, Bora E ^a   Rubinstein, Wendy S ^a,b   Taschner, Peter E ^c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chromosome 11q23; Hereditary paraganglioma; Imprinting; Mitochondrial complex II

Indexed keywords

FLAVOPROTEIN; FUMARIC ACID; IRON SULFUR PROTEIN; MEMBRANE PROTEIN; PROTEIN SUBUNIT; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID;

CARCINOGENESIS; CARDIOMYOPATHY; CITRIC ACID CYCLE; DISEASE TRANSMISSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENZYME SUBUNIT; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GENOME IMPRINTING; GROWTH RETARDATION; HEREDITARY OPTIC ATROPHY; HUMAN; LEIGH DISEASE; LEUKODYSTROPHY; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MULTIPLE ORGAN FAILURE; MUSCLE HYPOTONIA; MYOPATHY; NEUROPATHY; OXIDATION; PARAGANGLIOMA; PHEOCHROMOCYTOMA; REVIEW;

CELL NUCLEUS; CHROMOSOMES, HUMAN, PAIR 11; CITRIC ACID CYCLE; DNA, COMPLEMENTARY; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX II; GENOMIC IMPRINTING; HUMANS; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; MUTATION; OXIDOREDUCTASES; PHENOTYPE; SUCCINATE DEHYDROGENASE;

EID: 0034803010     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090100267     Document Type: Review

References (75)

1. Oxidative phosphorylation at the fin de siecle
2. Oxidative phosphorylation diseases
3. Nuclear-encoded defects of the mitochondrial respiratory chain, including glutaric acidemia
4. A high rate (20%-30%) of parental consanguinity in cytochrome-oxidase deficiency
5. Mitochondrial diseases in man and mouse
6. Mitochondrial DNA disorders
7. Nuclear genes and oxidative phosphorylation disorders: A review
8. Succinate: Quinone oxidoreductases. Variations on a conserved theme
9. Biochemical, physiological and medical aspects of ubiquinone function
10. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex
11. The electron transport chain in anaerobically functioning eukaryotes
12. Progress in understanding structure-function relationships in respiratory chain complex II
13. Analyzing your complexes: Structure of the quinol-fumarate reductase respiratory complex
14. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
15. The gene for the iron sulfur protein of succinate dehydrogenase (SDH-IP) maps to human chromosome 1p35-36.1
16. Compound heterozygous mutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome
17. Structural organization of the gene encoding the human iron-sulfur subunit of succinate dehydrogenase
18. Cytochrome b in human complex II (succinate-ubiquinone oxidoreductase): cDNA cloning of the components in liver mitochondria and chromosome assignment of the genes for the large (SDHC) and small (SDHD) subunits to 1q21 and 11q23
19. Characterization of the human SDHC gene encoding of the integral membrane proteins of succinate-quinone oxidoreductase in mitochondria
20. Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase
21. A human succinate-ubiquinone oxidoreductase CII-3 subunit gene ending in a polymorphic dinucleotide repeat is located within the sulfonylurea receptor (SUR) gene
22. Nuclear respiratory factors the pathways of nuclear-mitochondrial interaction
23. Promoter analysis of the human succinate dehydrogenase iron-protein gene-both nuclear respiratory factors NRF-1 and NRF-2 are required
24. Inborn errors of the Krebs cycle: A group of unusual mitochondrial diseases in human
25. Biochemical investigations and immunoblot analyses of two unrelated patients with an isolated deficiency in complex II of the mitochondrial respiratory chain
26. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome
27. Kearns-Sayre syndrome and complex II deficiency
28. Mitochondrial encephalomyopathy with decreased succinate-cytochrome c reductase activity
29. The investigation of respiratory chain disorders in heart using endomyocardial biopsies
30. Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency
31. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia
32. Molecular genetic study of 5 patients with succinate dehydrogenase deficiency
33. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: Comparison with denaturing gradient gel electrophoresis and nucleotide sequencing
34. Late-onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene
35. Subacute necrotizing encephalomyelopathy in an infant
36. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
37. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene
38. Novel mutations in the SDHD gene in pedigrees with familial carotid body paraganglioma and sensorineural hearing loss
39. Familial carotid body tumors: Case report and epidemiologic review
40. First experiences with genetic counselling based on predictive DNA diagnosis in hereditary glomus tumours (paragangliomas)
41. Genomic imprinting in hereditary glomus tumours: Evidence for new genetic theory
42. Mutations in SDHC cause autosomal dominant paraganglioma, type 3
43. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma
44. Allelotype of head and neck paragangliomas: Allelic imbalance is confined to the long arm of chromosome 11, the site of the predisposing locus PGL
45. Fine mapping of an imprinted gene for familial nonchromaffin paragangliomas, on chromosome 11q23
46. Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction
47. A high-resolution integrated map spanning the SDHD gene at 11q23: A 1.1-Mb BAC contig, a partial transcript map and fifteen new repeat polymorphisms in a tumor-suppressor region
48. Mutations in the SDHD gene are not only involved in hereditary paragangliomas in the head and neck region, but also in adrenal and extra-adrenal pheochromocytomas
49. Pheochromocytoma as an inherited abnormality: Report of the tenth affected kindred and review of the literature
50. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
51. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease
52. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms
53. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotype
54. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma
55. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
56. Identification of the von Hippel-Lindau disease tumor suppressor gene
57. Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
58. Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas
59. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases
60. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas
61. Genetic predisposition to phaeochromocytoma: Analysis of candidate genes GDNF, RET and VHL
62. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma
63. The Saccharomyces cerevisiae TCM62 gene encodes a chaperone necessary for the assembly of the mitochondrial succinate dehydrogenase (complex II)
64. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q
65. Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: Evidence for genetic heterogeneity
66. Mammalian cells with defective mitochondrial functions: A Chinese hamster mutant cell line lacking succinate dehydrogenase activity
67. A Chinese hamster mutant cell line with a defect in the integral membrane protein CII-3 of complex II of the mitochondrial electron transport chain
68. Molecular genetics of succinate:quinone oxidoreductase in eukaryotes
69. A methyl viologen-sensitive mutant of the nematode Caenorhabditis elegans
70. Oxygen-dependent perturbation of life span and aging rate in the nematode
71. Effects of oxygen on protein carbonyl and aging in Caenorhabditis elegans mutants with long (age-1) and short (mev-1) life spans
72. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes
73. Extension of life-span with superoxide dismutase/catalase mimetics
74. Genetics of familial paragangliomas: Past, present and future
75. Perspectives on oxygen sensing